104 related articles for article (PubMed ID: 9863006)
1. Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors.
Khare L; Sabourin CL; De Young BR; Jamasbi RJ; Stoner GD
Int J Oncol; 1999 Jan; 14(1):33-40. PubMed ID: 9863006
[TBL] [Abstract][Full Text] [Related]
2. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
3. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.
Tomita K; van Bokhoven A; Jansen CF; Bussemakers MJ; Schalken JA
Biochem Biophys Res Commun; 2000 Jan; 267(3):870-4. PubMed ID: 10673383
[TBL] [Abstract][Full Text] [Related]
4. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
[TBL] [Abstract][Full Text] [Related]
5. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin and alpha-catenin expression in human esophageal cancer.
Kadowaki T; Shiozaki H; Inoue M; Tamura S; Oka H; Doki Y; Iihara K; Matsui S; Iwazawa T; Nagafuchi A
Cancer Res; 1994 Jan; 54(1):291-6. PubMed ID: 8261454
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines.
El-Hariry I; Jordinson M; Lemoine N; Pignatelli M
J Pathol; 1999 Jun; 188(2):155-62. PubMed ID: 10398158
[TBL] [Abstract][Full Text] [Related]
8. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
[TBL] [Abstract][Full Text] [Related]
9. Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats.
Jung KY; Dean D; Jiang J; Gaylor S; Griffith WH; Burghardt RC; Parrish AR
Mech Ageing Dev; 2004 Jun; 125(6):445-53. PubMed ID: 15178134
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
11. Aberrant E-cadherin and gamma-catenin expression in malignant mesothelioma and its diagnostic and biological relevance.
Orecchia S; Schillaci F; Salvio M; Libener R; Betta PG
Lung Cancer; 2004 Aug; 45 Suppl 1():S37-43. PubMed ID: 15261432
[TBL] [Abstract][Full Text] [Related]
12. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
13. Cadherin-11 is expressed in invasive breast cancer cell lines.
Pishvaian MJ; Feltes CM; Thompson P; Bussemakers MJ; Schalken JA; Byers SW
Cancer Res; 1999 Feb; 59(4):947-52. PubMed ID: 10029089
[TBL] [Abstract][Full Text] [Related]
14. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness.
Shimoyama Y; Nagafuchi A; Fujita S; Gotoh M; Takeichi M; Tsukita S; Hirohashi S
Cancer Res; 1992 Oct; 52(20):5770-4. PubMed ID: 1394201
[TBL] [Abstract][Full Text] [Related]
15. Cadherin switching in human prostate cancer progression.
Tomita K; van Bokhoven A; van Leenders GJ; Ruijter ET; Jansen CF; Bussemakers MJ; Schalken JA
Cancer Res; 2000 Jul; 60(13):3650-4. PubMed ID: 10910081
[TBL] [Abstract][Full Text] [Related]
16. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Yokomakura N; Ishigami S; Aikou T
J Surg Oncol; 2007 Feb; 95(2):148-55. PubMed ID: 17262732
[TBL] [Abstract][Full Text] [Related]
17. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
[TBL] [Abstract][Full Text] [Related]
18. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion.
Davies G; Jiang WG; Mason MD
Anticancer Res; 1999; 19(1A):547-52. PubMed ID: 10226596
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
20. Biochemical analysis and subcellular distribution of E-cadherin-catenin in adenocarcinomas of the gastro-oesophageal junction.
Wijnhoven BP; Tucker ET; Dinjens WN; Tilanus HW; Pignatelli M
Anticancer Res; 2004; 24(3a):1369-75. PubMed ID: 15274297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
